A comparison of multiple patient reported outcome measures in identifying major depressive disorder in people with multiple sclerosis

Journal of Psychosomatic Research

Volumn 79, Issue 6, 2015, Pages 550-557

  Amtmann, Dagmar ^a   Bamer, Alyssa M ^a   Johnson, Kurt L ^a   Ehde, Dawn M ^a   Beier, Meghan L ^a   Elzea, Jamie L ^a   Bombardier, Charles H ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Beck depression; CESD; Depression; Diagnostic accuracy; Neuro QOL; PHQ; PROMIS; SCID

Indexed keywords

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; CENTER FOR EPIDEMIOLOGIC STUDIES DEPRESSION SCALE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION ASSESSMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MULTIPLE SCLEROSIS; NEUROLOGICAL QUALITY OF LIFE; PATIENT HEALTH QUESTIONNAIRE 9; PATIENT REPORTED OUTCOMES MEASUREMENT INFORMATION SYSTEM; QUALITY OF LIFE; SELF REPORT; SENSITIVITY AND SPECIFICITY; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; COMPARATIVE STUDY; COMPLICATION; DEPRESSIVE DISORDER, MAJOR; EDUCATIONAL STATUS; ETHNIC GROUP; HEALTH STATUS; MIDDLE AGED; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; SOCIOECONOMICS; TREATMENT OUTCOME;

CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER, MAJOR; EDUCATIONAL STATUS; ETHNIC GROUPS; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PSYCHIATRIC STATUS RATING SCALES; REPRODUCIBILITY OF RESULTS; ROC CURVE; SOCIOECONOMIC FACTORS; SURVEYS AND QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 84941254430     PISSN: 00223999     EISSN: 18791360     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2015.08.007     Document Type: Article

References (61)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (Text Revision) 2000, American Psychiatric Association, Washington, DC.
2. Amtmann D., Kim J., Chung H., Bamer A.M., Askew R.L., Wu S., Cook K.F., Johnson K.L. Comparing CESD-10, PHQ-9, and PROMIS depression instruments in individuals with multiple sclerosis. Rehabil. Psychol. 2014, 59:220-229.
3. Andresen E.M., Malmgren J.A., Carter W.B., Patrick D.L. Screening for depression in well older adults: evaluation of a short form of the CES-D. Am. J. Prev. Med. 1994, 10:77-84.
4. Arnett P.A., Higginson C.I., Voss W.D., Wright B., Bender W.I., Wurst J.M., Tippin J.M. Depressed mood in multiple sclerosis: relationship to capacity-demanding memory and attentional functioning. Neuropsychology 1999, 13:434-446.
5. Beck A.T., Steer R.A., Brown G.K. BDI-Fast Screen for Medical Patients: Manual 2000, Pearson, San Antonio, TX.
6. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry 1961, 4:561.
7. Benedict R.H., Fishman I., McClellan M.M., Bakshi R., Weinstock-Guttman B. Validity of the Beck depression inventory-fast screen in multiple sclerosis. Mult. Scler. 2003, 9:393-396.
8. Benedict R.H., Cookfair D., Gavett R., Gunther M., Munschauer F., Garg N., et al. Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). J. Int. Neuropsychol. Soc. 2006, 12:549-558.
9. Bowen J., Gibbons L., Gianas A., Kraft G.H. Self-administered Expanded Disability Status Scale with functional system scores correlates well with a physician-administered test. Mult. Scler. 2001, 7:201-206.
10. Cella D., Lai J.S., Nowinski C.J., Victorson D., Peterman A., Miller D., Bethoux F., Heinemann A., Rubin S., Cavazos J.E., Reder A.T., Sufit R., Simuni T., Holmes G.L., Siderowf A., Wojna V., Bode R., McKinney N., Podrabsky T., Wortman K., Choi S., Gershon R., Rothrock N., Moy C. Neuro-QOL: brief measures of health-related quality of life for clinical research in neurology. Neurology 2012, 78:1860-1867.
11. Cella D., Riley W., Stone A., Rothrock N., Reeve B., Yount S., Amtmann D., Bode R., Buysse D., Choi S., Cook K., DeVellis R., DeWalt D., Fries J.F., Gershon R., Hahn E.A., Lai J.-S., Pilkonis P., Revicki D., Rose M., Weinfurt K., Hays R. The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. J. Clin. Epidemiol. 2010, 63:1179-1194.
12. Choi S.W., Podrabsky T., McKinney N., Schalet B.D., Cook K.F., Cella D. PROsetta Stone Analysis Report: A Rosetta Stone for Patient Reported Outcomes 2013, Northwestern University, Available at: http://www.prosettastone.org/AnalysisReport/Documents/PROsettaStoneAnalysisReportVol1.pdf.
13. Conway D.S., Miller D.M., O'Brien R.G., Cohen J.A. Long term benefit of multiple sclerosis treatment: an investigation using a novel data collection technique. Mult. Scler. 2012, 18:1617-1624.
14. Cozby P.C. Methods of Behavioral Research 2009, McGraw-Hill, New York, NY. Tenth edition.
15. D'Alisa S., Miscio G., Baudo S., Simone A., Tesio L., Mauro A. Depression is the main determinant of quality of life in multiple sclerosis: a classification-regression (CART) study. Disabil. Rehabil. 2006, 28:307-314.
16. Ehde D.M., Bombardier C.H. Depression in persons with multiple sclerosis. Phys. Med. Rehabil. Clin. N. Am. 2005, 16:437-448. (ix).
17. Feinstein A. Multiple sclerosis, depression, and suicide. BMJ 1997, 315:691-692.
18. Feinstein A. An examination of suicidal intent in patients with multiple sclerosis. Neurology 2002, 59:674-678.
19. Feinstein A. Multiple sclerosis and depression. Mult. Scler. 2011, 17:1276-1281.
20. Feinstein A., Magalhaes S., Richard J.F., Audet B., Moore C. The link between multiple sclerosis and depression. Nat. Rev. Neurol. 2014, 10:507-517.
21. Ferrando S.J., Samton J., Mor N., Nicora S., Findler M., Apatoff B. Patient Health Questionnaire-9 to screen for depression in outpatients with multiple sclerosis. Int. J. MS Care 2007, 9:99-103.
22. First M., Spitzer R., Gibbon M., Williams J. Structured Clinical Interview for DSM-IV-TR Axis I Disorders - Patient Edition (SCID-I/P, 4/2005 Revision) 2005, Biometrics Research Department, New York State Psychiatric Institute, New York.
23. First M., Spitzer R., Williams J., Gibbon M. Structured Clinical Interview for DSM-IV (SCID) 1995, American Psychiatric Association, Washington, DC.
24. Gershon R.C., Lai J.S., Bode R., Choi S., Moy C., Bleck T., Miller D., Peterman A., Cella D. Neuro-QOL: quality of life item banks for adults with neurological disorders: item development and calibrations based upon clinical and general population testing. Qual. Life Res. 2012, 21:475-486.
25. Goldman Consensus Group The Goldman Consensus statement on depression in multiple sclerosis. Mult. Scler. 2005, 11:328-337.
26. Grimes D.A., Schulz K.F. Refining clinical diagnosis with likelihood ratios. Lancet 2005, 365:1500-1505.
27. Gunzler D.D., Perzynski A., Morris N., Bermel R., Lewis S., Miller D. Disentangling multiple sclerosis and depression: an adjusted depression screening score for patient-centered care. J. Behav. Med. 2014, (Epub 2014/06/02).
28. Honarmand K., Feinstein A. Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patients. Mult. Scler. 2009, 15:1518-1524.
29. Kroenke K., Spitzer R.L., Williams J.B. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med. Care 2003, 41:1284-1292.
30. Kroenke K., Spitzer R.L., Williams J.B.W. The PHQ-9. J. Gen. Intern. Med. 2001, 16:606-613.
31. Kroenke K., Spitzer R.L., Williams J.B.W., Löwe B. The Patient Health Questionnaire somatic, anxiety, and depressive symptom scales: a systematic review. Gen. Hosp. Psychiatry 2010, 32:345-359.
32. Liu H., Cella D., Gershon R., Shen J., Morales L.S., Riley W., Hays R.D. Representativeness of the Patient-Reported Outcomes Measurement Information System Internet panel. J. Clin. Epidemiol. 2010, 63:1169-1178.
33. Lowe B., Unutzer J., Callahan C.M., Perkins A.J., Kroenke K. Monitoring depression treatment outcomes with the Patient Health Questionnaire-9. Med. Care 2004, 42:1194-1201.
34. Minden S.L., Feinstein A., Kalb R.C., Miller D., Mohr D.C., Patten S.B., Bever C., Schiffer R.B., Gronseth G.S., Narayanaswami P. Evidence-based guideline: assessment and management of psychiatric disorders in individuals with MS: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 2014, 82:174-181.
35. Mohr D.C., Hart S.L., Julian L., Tasch E.S. Screening for depression among patients with multiple sclerosis: two questions may be enough. Mult. Scler. 2007, 13:215-219.
36. National Institute of Neurological Disorders and Stroke User manual for the Quality of Life in Neurological Disorders (Neuro-QOL) measures. Version 1.0 Available at:. http://www.neuroqol.org/HowDoI/UserManual/User%20Manual/Neuro-QOL_UserManual.pdf.
37. Pandya R., Metz L., Patten S.B. Predictive value of the CES-D in detecting depression among candidates for disease-modifying multiple sclerosis treatment. Psychosomatics 2005, 46:131-134.
38. Patten S.B., Beck C.A., Williams J.V., Barbui C., Metz L.M. Major depression in multiple sclerosis: a population-based perspective. Neurology 2003, 61:1524-1527.
39. Patten S.B., Williams J.V., Lavorato D.H., Koch M., Metz L.M. Depression as a predictor of occupational transition in a multiple sclerosis cohort. Funct. Neurol. 2013, 28:275-280.
40. Patten S.B., Burton J.M., Fiest K.M., Wiebe S., Bulloch A.G., Koch M., et al. Validity of four screening scales for major depression in MS. Mult. Scler. 2015, (Epub ahead of print).
41. Pilkonis P.A., Choi S.W., Reise S.P., Stover A.M., Riley W.T., Cella D. Item banks for measuring emotional distress from the Patient-Reported Outcomes Measurement Information System (PROMIS®): depression, anxiety, and anger. Assessment 2011, 18:263-283.
42. Pompili M., Forte A., Palermo M., Stefani H., Lamis D., Serafini G., Amore M., Girardi P. Suicide risk in multiple sclerosis: a systematic review of current literature. J. Psychosom. Res. 2012, 73:411-417.
43. PROMIS Depression: A Brief Guide to the PROMIS Depression Instruments. Patient Reported Outcomes Measurement Information System 2014, (Available at: https://www.assessmentcenter.net/documents/PROMIS%20Depression%20Scoring%20Manual.pdf).
44. Radloff L.S. The CES-D scale: A self-report depression scale for research in the general population. Appl. Psychol. Meas. 1977, 1:385-401.
45. Rohde P., Lewinsohn P.M., Seeley J.R. Comparability of telephone and face-to-face interviews in assessing axis I and II disorders. Am. J. Psychiatry 1997, 154:1593-1598.
46. Senders A., Hanes D., Bourdette D., Whitham R., Shinto L. Reducing survey burden: feasibility and validity of PROMIS measures in multiple sclerosis. Mult. Scler. 2014, 20:1102-1111.
47. Simon G.E., Revicki D., VonKorff M. Telephone assessment of depression severity. J. Psychiatr. Res. 1993, 27:247-252.
48. Sjonnesen K., Berzins S., Fiest K.M., Bulloch A.G.M, Metz L.M., Thombs B.D., Patten S.B. Evaluation of the 9-item Patient Health Questionnaire (PHQ-9) as an assessment instrument for symptoms of depression in patients with multiple sclerosis. Postgrad. Med. 2012, 124:69-77.
49. Skokou M., Soubasi E., Gourzis P. Depression in multiple sclerosis: a review of assessment and treatment approaches in adult and pediatric populations. ISRN Neurol. 2012, 2012:427102.
50. Spitzer R.L., Kroenke K., Williams J.B.W. Validation and utility of a self-report version of PRIME-MD. JAMA 1999, 282:1737-1744.
51. Spitzer R.L., Williams J.B., Kroenke K., Linzer M., deGruy F.V., Hahn S.R., Brody D., Johnson J.G. Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA 1994, 272:1749-1756.
52. StataCorp Stata Statistical Software: Release 12 2011, StataCorp LP, College Station, TX.
53. Sullivan M.J., Weinshenker B., Mikail S., Bishop S.R. Screening for major depression in the early stages of multiple sclerosis. Can. J. Neurol. Sci. 1995, 22:228-231.
54. Tarrants M., Oleen-Burkey M., Castelli-Haley J., Lage M.J. The impact of comorbid depression on adherence to therapy for multiple sclerosis. Mult. Scler. Int. 2011, 2011:271321.
55. Verdier-Taillefer M.H., Gourlet V., Fuhrer R., Alperovitch A. Psychometric properties of the Center for Epidemiologic Studies-Depression scale in multiple sclerosis. Neuroepidemiology 2001, 20:262-267.
56. Watson T.M., Ford E., Worthington E., Lincoln N.B. Validation of mood measures for people with multiple sclerosis. Int. J. MS Care 2014, 16:105-109.
57. Weissman M.M., Sholomskas D., Pottenger M., Prusoff B.A., Locke B.Z. Assessing depressive symptoms in five psychiatric populations: a validation study. Am. J. Epidemiol. 1977, 106:203-214.
58. Whooley M.A., Avins A.L., Miranda J., Browner W.S. Case-finding instruments for depression. Two questions are as good as many. J. Gen. Intern. Med. 1997, 12:439-445.
59. Williams J.W., Noel P.H., Cordes J.A., Ramirez G., Pignone M. Is this patient clinically depressed?. JAMA 2002, 287:1160-1170.
60. Youden W.J. Index for rating diagnostic tests. Cancer 1950, 3:32-35.
61. Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatr. Scand. 1983, 67:361-370.